APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy
about
The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survivalAssociation of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal diseaseSystematic reviews of animal models: methodology versus epistemology.FSGS: Diagnosis and Diagnostic Work-UpEthnic Differences in Childhood Nephrotic SyndromeSecondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to GlomerulosclerosisAPOL1 Kidney Disease Risk Variants: An Evolving LandscapeOpportunities and Challenges of Genotyping Patients With Nephrotic Syndrome in the Genomic EraInsights into the genetic architecture of diabetic nephropathyKidney disease: new technologies translate mechanisms to cureHypertension and chronic kidney disease: controversies in pathogenesis and treatmentPodocyte pathology and nephropathy - sphingolipids in glomerular diseasesClinical perspectives on lupus genetics: advances and opportunitiesHIV and chronic kidney diseaseAddressing the global burden of chronic kidney disease through clinical and translational researchAPOL1 and nephropathy progression in populations of African ancestryAPOL1 kidney risk alleles: population genetics and disease associationsUpdate on current management of chronic kidney disease in patients with HIV infectionDrug-induced glomerular disease: direct cellular injury.The African diaspora: history, adaptation and healthAPOL1 toxin, innate immunity, and kidney injuryPopulation ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the curesIn vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic StressA review of the Institute of Medicine's analysis of using chimpanzees in biomedical researchAnimal models and conserved processesWhat Do We Know about Opioids and the Kidney?Insights into kidney diseases from genome-wide association studies.Social Determinants of Racial Disparities in CKD.Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension TrialAssociation Analysis of the Cubilin (CUBN) and Megalin (LRP2) Genes with ESRD in African Americans.Lack of Association of the APOL1 G3 Haplotype in African Americans with ESRDGetting to 90-90-90 in paediatric HIV: What is needed?Evolution of the primate trypanolytic factor APOL1Collapsing glomerulopathy, the Saudi Arabian scenario. A study of 31 cases and a review of literaturePersonalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal DiseasesAPOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis.Explaining the racial difference in AKI incidenceAPOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.Research capacity. Enabling the genomic revolution in Africa.
P2860
Q24594836-8E386A24-2728-45AA-86F1-F999D5AFE594Q24599916-F5C9E840-04EF-4372-AEA1-A8199A8F176CQ24629614-E77AF88F-E9B6-41F7-B794-3C98C61D8441Q26744558-7EC9B6E4-5451-4FD7-92E4-C9F7E3C12EE9Q26752347-2C835010-61DD-49F9-9686-3935E200D258Q26752830-1DDAB9DA-87A6-43F5-988E-B18367A86C5EQ26799191-B4B74B15-D31A-4979-A66C-B7B6E5291F56Q26799197-8556C1CB-79DE-4A50-9F2B-238A1DA8C309Q26823352-B88CAAE4-76DC-4B29-829C-B2D324F558EBQ26825227-0E075186-96BB-4809-A3C2-2CC846B2BD66Q26851271-B52B662D-65B5-42E2-8C9B-BFED8FB2144CQ26852463-E6894D1F-9D74-4E96-BE27-0EF257D38FC5Q27001690-CCF1F934-7BE4-4DC7-9D23-B3DCDBEA5267Q27010688-1880C82B-5B76-4414-A445-B799E2D19EA3Q27014158-48067FBE-A442-4776-BA56-4329F756D20AQ27022275-AB173F6B-9E0D-4009-AF69-00C221095453Q27024261-B0DF435A-C71E-4CF9-95D8-D56E9E9806BCQ27691460-751BCF4D-7517-4166-9566-5A0C0CDAC4A3Q27692666-79D2509A-3890-4E1E-80E9-E7FEDD670820Q28075805-88D016FB-782D-4943-A905-8622D94ACC83Q28085667-5C20130C-6DE8-4145-AA2B-937925ACE106Q28391758-3E82E083-E6DA-488C-808C-4E271591ACB4Q28546164-C4C5E72B-03FC-40D1-B8CB-32B5EB02C700Q28659265-51829FBB-3680-47EF-9E7A-8DF21D783896Q28710144-BF0B4E70-45B0-44AB-A9DA-73AEBC476552Q30238812-711304CD-3208-4FCD-BD4B-6D63537A34AEQ30248678-6723C7D5-84EA-47E3-A8B7-77BF0C24ECACQ30250319-6C974CBD-7949-4573-9512-9019B8E846F1Q30277219-68CBE32E-1944-4765-BB98-F3D543325474Q30352406-DB0BC994-C3B8-4DDD-8863-00EB582719BBQ30359344-EE3CDF55-65E2-4B67-BAF2-8F16EC0B5001Q30385352-A15BA06C-412C-4844-A746-9E8F301315ADQ33665446-44BDEF76-FC8B-40A8-B15E-B0363B5AC622Q33735329-259831D1-9146-49AB-9F70-849426D15BD9Q33838866-FE3E6ED1-31BF-41A2-9B69-D60877C8BDF9Q33866444-8F972768-2EC0-4068-BD30-1EF4A9C995E4Q33974656-083F5FBB-2C23-40F4-8F86-4EBA2565C6A4Q34001289-7995DB73-4F3F-492C-8A86-BAA6148F88B1Q34008876-7ABC794D-61BB-4AB5-905D-45A27EC4AB24Q34068017-144D16AB-8450-40EF-9846-CC89F08DE681
P2860
APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
APOL1 genetic variants in foca ...... and HIV-associated nephropathy
@ast
APOL1 genetic variants in foca ...... and HIV-associated nephropathy
@en
APOL1 genetic variants in foca ...... and HIV-associated nephropathy
@nl
type
label
APOL1 genetic variants in foca ...... and HIV-associated nephropathy
@ast
APOL1 genetic variants in foca ...... and HIV-associated nephropathy
@en
APOL1 genetic variants in foca ...... and HIV-associated nephropathy
@nl
prefLabel
APOL1 genetic variants in foca ...... and HIV-associated nephropathy
@ast
APOL1 genetic variants in foca ...... and HIV-associated nephropathy
@en
APOL1 genetic variants in foca ...... and HIV-associated nephropathy
@nl
P2093
P2860
P50
P3181
P356
P1476
APOL1 genetic variants in foca ...... and HIV-associated nephropathy
@en
P2093
Cheryl A Winkler
David Friedman
Donna M Michel
Eric E Simon
George W Nelson
Giulio Genovese
Jeffrey R Schelling
Jeffrey S Berns
Karmini Sampath
Martin Pollak
P2860
P304
P3181
P356
10.1681/ASN.2011040388
P407
P577
2011-11-01T00:00:00Z